Effect of Hepatic Impairment on M2951 (BTK Inhibitor) PK
Clinical trial NCT04546789 · COMPLETED
Trial details
- NCT number
- NCT04546789
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2021-05-16
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.